RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,029 | +22.0% | 20,343 | 0.0% | 0.00% | – |
| Q2 2023 | $50,044 | -11.6% | 20,343 | -18.7% | 0.00% | – |
| Q1 2023 | $56,584 | -36.1% | 25,037 | 0.0% | 0.00% | – |
| Q4 2022 | $88,570 | -92.0% | 25,037 | -17.7% | 0.00% | -100.0% |
| Q3 2022 | $1,110,043 | +88.1% | 30,430 | -0.9% | 0.00% | – |
| Q2 2022 | $590,035 | +55.6% | 30,705 | +116.1% | 0.00% | – |
| Q1 2022 | $379,272 | +72.4% | 14,206 | +69.0% | 0.00% | – |
| Q3 2021 | $220,000 | -22.0% | 8,407 | -4.7% | 0.00% | – |
| Q2 2021 | $282,000 | -3.4% | 8,820 | +6.2% | 0.00% | – |
| Q1 2021 | $292,000 | +3.5% | 8,307 | -5.4% | 0.00% | – |
| Q4 2020 | $282,000 | -7.8% | 8,780 | +8.1% | 0.00% | – |
| Q3 2020 | $306,000 | -12.6% | 8,122 | 0.0% | 0.00% | – |
| Q2 2020 | $350,000 | – | 8,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |